The effect of adding hyaluronidase to local anesthetic for upper limb nerve block anesthesia

The effect of adding hyaluronidase to 0.5% ropivacaine during axillary brachial plexus block

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000964

Enrollment

Registered

2013-12-20

Start date

2013-11-19

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : 1500 units of hyaluronidase is mixed with 0.5% ropivacaine 25-30ml for axillary brachial plexus block in the experimental hyaluronidase group. For the control group, only 25-30ml of 0.5% ropiva

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists classification 1 or 2 patients requiring axillary brachial plexus block for upper limb surgery.

Exclusion criteria

Exclusion criteria: Age under 20 years, neurologic deficit in the upper extrimeties, chronic obstructive pulmonary disease, uncompensated cardiac disease, renal insufficiency, cerebrovascular disease, allergic reaction to study drugs, systemic infection or malignancy

Design outcomes

Primary

Measure	Time frame
Time to ready to surgery (min)	—

Secondary

Measure	Time frame
Sensory block onset (min);Motor block onset (min);Presence of incomplete block ;Sensory/motor paresthesia duration ;Time to 1st rescue analgesics (min);Patient satisfaction (1-7)	—

Countries

Korea, Republic of

Contacts

Public ContactWonuk Koh

Asan Medical Center

Outcome results